EUROFINS NV overview

MGI Tech and Eurofins Genomics Partner to Elevate Precision Health with Revolutionary DNBSEQ-T20×2 Sequencer and Related Technologies PR Newswire SHENZHEN, China, March 4, 2024 SHENZHEN, China , March 4, 2024 /PRNewswire/ -- MGI Tech, a company committed to building core tools and technology to lead life science, today proudly announced a milestone collaboration with Eurofins Genomics Europe Genotyping A/S ("Eurofins Genomics"), which has placed a corporate order of the revolutionary...

MELBOURNE, Australia, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a clinical-stage pharmaceutical company developing medicinal cannabinoid and psychedelic therapies for unmet medical needs, is delighted to announce that it has engaged multinational contract development and manufacturing organisation (CDMO) Eurofins Scientific (‘Eurofins’) to manufacture ReneCann therapeutic for topical applications. ReneCann...

MELBOURNE, Australia, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a clinical-stage pharmaceutical company developing medicinal cannabinoid and psychedelic therapies for unmet medical needs, is delighted to announce that it has engaged multinational contract development and manufacturing organisation (CDMO) Eurofins Scientific (‘Eurofins’) to manufacture Incannex’s two distinct medicated chewable products...

Eurofins Viracor Opens Expansive Laboratory in Lenexa, KS PR Newswire LENEXA, Kan., Oct. 6, 2022 110,000 square foot, state-of-the-art facility increases infectious disease and immunology testing capacity to support growth of clinical, biopharma, and transplant diagnostic services LENEXA, Kan. , Oct. 6, 2022 /PRNewswire/ -- Eurofins Viracor, a leader in infectious disease and immunology testing, today celebrated the opening of its expansive new laboratory in Lenexa, KS. The 110,000 square foot,...

Eurofins Viracor launches Epstein-Barr Virus (EBV) inSIGHT™ to Evaluate T Cell Mediated Immunity to Epstein-Barr Virus PR Newswire LENEXA, Kan., Oct. 3, 2022 LENEXA, Kan. , Oct. 3, 2022 /PRNewswire/ -- Eurofins Viracor, a leader in infectious disease and immunology testing, launches EBV inSIGHT™ , a functional T Cell test to measure CD4 and CD8 Epstein-Barr virus-specific T cell immune response. The test joins the innovative inSIGHT diagnostic portfolio of virus-specific cell mediated...

Eurofins Discovery Announces Acquisition of DiscoveryBioMed PR Newswire SAN DIEGO, July 6, 2022 SAN DIEGO , July 6, 2022 /PRNewswire/ -- Eurofins Discovery , the leading brand with over 35 years of success providing a complete solution of products and services for drug discovery, today announced the acquisition of DiscoveryBioMed, a contract research organization (CRO) focused on developing novel human bioassays utilizing cells from diseased and normal human tissues. Eurofins Discovery acquired...

Eurofins Discovery Announces Acquisition of DiscoveryBioMed PR Newswire SAN DIEGO, July 5, 2022 SAN DIEGO , July 5, 2022 /PRNewswire/ -- Eurofins Discovery , the leading brand with over 35 years of success providing a complete solution of products and services for drug discovery, today announced the acquisition of DiscoveryBioMed, a contract research organization (CRO) focused on developing novel human bioassays utilizing cells from diseased and normal human tissues. Eurofins Discovery acquired...

Eurofins DiscoverX Celebrates Shanghai Office Opening PR Newswire SHANGHAI, June 29, 2022 SHANGHAI , June 29, 2022 /PRNewswire/ -- Eurofins DiscoverX (Eurofins DiscoverX Products LLC), a global industry leader of products for small and large molecule drug discovery and QC lot release, today announced the official opening of its new China biotechnology office in Shanghai . The launch of Eurofins DiscoverX ( Shanghai ) Ltd. broadens its Asia-Pacific operations directly into the China market. This...